Literature DB >> 6848155

Cimetidine and portal pressure in chronic liver disease.

M J Cole, T F Shapero, E A Saibil.   

Abstract

Portal pressure was determined in 10 patients with chronic liver disease before and after an infusion of cimetidine. The drug had no significant effect on portal hypertension. Suggestions that histamine H2-receptor antagonists, by decreasing portal pressure, may be useful in the management of bleeding from esophageal varices are not supported by these results.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6848155      PMCID： PMC1874813     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


  7 in total

1.  Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients.

Authors:  B Millette; P M Huet; P Lavoie; A Viallet
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

2.  Wedged and free hepatic venous pressure measured with a balloon catheter.

Authors:  R J Groszmann; M Glickman; A T Blei; E Storer; H O Conn
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

3.  Histamine H1- and H2-receptor vasodilation of canine intestinal circulation.

Authors:  W Pawlik; L L Tague; B L Tepperman; T A Miller; E D Jacobson
Journal:  Am J Physiol       Date:  1977-09

4.  Evidence for both histamine H1- and H2-receptors in the gastric vasculature of the cat.

Authors:  C A Harvey; D A Owen; K D Shaw
Journal:  Br J Pharmacol       Date:  1980-05       Impact factor: 8.739

5.  Effect of histamine and histamine antagonists on portal blood pressure in patients with hepatosplenic schistosomiasis.

Authors:  M A El-Gendi; S H Nassar
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

6.  Reduction of liver blood flow and propranolol metabolism by cimetidine.

Authors:  J Feely; G R Wilkinson; A J Wood
Journal:  N Engl J Med       Date:  1981-03-19       Impact factor: 91.245

7.  Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.

Authors:  D Lebrec; T Poynard; P Hillon; J P Benhamou
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.